(Q43945835)

28 November 2017

title

Serum levels of calreticulin in correlation with disease activity in patients with rheumatoid arthritis (English)

1 reference

28 November 2017

Min Ni

1

1 reference

28 November 2017

Wei Wei

2

1 reference

28 November 2017

Yichao Wang

3

1 reference

28 November 2017

Na Zhang

4

1 reference

28 November 2017

Hongmei Ding

5

1 reference

28 November 2017

Chen Shen

6

1 reference

28 November 2017

Fang Zheng

7

1 reference

28 November 2017

publication date

27 March 2013

1 reference

Journal of Clinical Immunology

28 November 2017

published in

1 reference

28 November 2017

volume

33

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

947-953

1 reference

The pathogenesis of rheumatoid arthritis

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis pat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

Pathophysiological roles of calreticulin in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

Functional analysis of recombinant calreticulin fragment 39-272: implications for immunobiological activities of calreticulin in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

The ins and outs of calreticulin: from the ER lumen to the extracellular space.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

A role for calreticulin in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

A mechanism of release of calreticulin from cells during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9885-2

Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA

21 January 2018

1 reference

12 December 2020

The Disease Activity Score and the EULAR response criteria

1 reference

12 December 2020

Disease activity-guided rituximab therapy in rheumatoid arthritis: the effects of re-treatment in initial nonresponders versus initial responders

1 reference

12 December 2020

Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity

1 reference

12 December 2020

Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of t

1 reference

12 December 2020

Evidence supporting the benefit of early intervention in rheumatoid arthritis

1 reference

12 December 2020

High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.

1 reference

12 December 2020

Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA

1 reference

12 December 2020

Diagnosis and management of rheumatoid arthritis

1 reference

12 December 2020

Serum adenosine deaminase may predict disease activity in rheumatoid arthritis

1 reference

12 December 2020

Rheumatoid arthritis in 2003: where are we now with treatment?

1 reference

12 December 2020

Assessment of disease activity and treatment outcomes in rheumatoid arthritis.

1 reference

12 December 2020

10.1007/S10875-013-9885-2

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

1038221814

0 references

1 reference